5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.83▲ | 0.83▲ | 0.82▲ | 0.84▼ | 0.84▼ |
MA10 | 0.82▲ | 0.82▲ | 0.82▲ | 0.87▼ | 0.89▼ |
MA20 | 0.82▲ | 0.83▲ | 0.84▲ | 0.85▼ | 0.95▼ |
MA50 | 0.85▼ | 0.86▼ | 0.87▼ | 0.90▼ | 1.25▼ |
MA100 | 0.87▼ | 0.86▼ | 0.84▼ | 0.97▼ | 1.67▼ |
MA200 | 0.85▼ | 0.89▼ | 0.89▼ | 1.15▼ | 2.52▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.005▲ | 0.004▲ | 0.001▲ | -0.002▼ | 0.010▲ |
RSI | 55.477▲ | 50.016▲ | 48.226▼ | 46.078▼ | 41.630▼ |
STOCH | 74.320 | 70.960 | 33.254 | 19.626▼ | 29.095 |
WILL %R | -2.830▲ | -6.364▲ | -50.481 | -56.148 | -72.465 |
CCI | 133.924▲ | 111.145▲ | 60.619 | -123.844▼ | -75.461 |
Thursday, May 29, 2025 12:36 AM
SCYNEXIS, Inc. (NASDAQ:SCYX) has officially restarted patient dosing in its Phase III MARIO trial for Brexafemme (ibrexafungerp) after the FDA lifted a nearly two-year clinical hold.
|
Wednesday, May 28, 2025 09:31 PM
SCYNEXIS, Inc. (NASDAQ:SCYX) has officially restarted patient dosing in its Phase III MARIO trial for Brexafemme (ibrexafungerp) after the FDA lifted a nearly two-year clinical hold. The hold, ...
|
Wednesday, April 30, 2025 05:00 PM
Get SCYNEXIS alerts: SCYNEXIS (NASDAQ:SCYX – Get Free Report) last announced its quarterly earnings data on Wednesday, March 12th. The company reported ($0.09) EPS for the quarter, beating the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 0.8205 | 0.8384 | 0.8205 | 0.8384 | 11,095 |
13/06/25 | 0.82 | 0.8315 | 0.8002 | 0.8075 | 99,492 |
12/06/25 | 0.87 | 0.8808 | 0.8202 | 0.822 | 140,908 |
11/06/25 | 0.88 | 0.898 | 0.8705 | 0.8846 | 47,785 |
10/06/25 | 0.89 | 0.8904 | 0.857 | 0.8629 | 66,146 |
09/06/25 | 0.90 | 0.9014 | 0.86 | 0.86 | 131,220 |
06/06/25 | 0.9123 | 0.92 | 0.864 | 0.918 | 61,433 |
05/06/25 | 0.93 | 0.93 | 0.85 | 0.8857 | 93,668 |
04/06/25 | 0.871 | 0.949 | 0.871 | 0.939 | 106,360 |
03/06/25 | 0.88 | 0.8992 | 0.8501 | 0.8838 | 56,239 |
|
|
||||
|
|
||||
|
|